Search results
Author(s):
Giuseppe Rosano
,
Harriette Van Spall
Added:
5 months ago
ESC 23 – Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Prof Giuseppe Rosano (St George’s Hospitals NHS Trust University of London, UK), President of HFA to distil the key messages from the 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
Prof Rosano summarises the retained ejection fraction…
View more
Author(s):
Josep Comin-Colet
Added:
8 years ago
Author(s):
Carolyn Lam
Added:
8 years ago
Author(s):
Sunil K Nadar
,
Osama Tariq
Added:
3 years ago
The latest guidelines on the diagnosis and management of heart failure (HF) published by the European Society of Cardiology (ESC) introduced a new class of HF: HF with mid-range ejection fraction (HFmrEF).1 This was in addition to the previously-defined classes: HF with reduced ejection fraction (HFrEF), in which the left ventricular ejection fraction (LVEF) is below 40%, and HF with preserved…
View more
Author(s):
Frank Ruschitzka
,
John JV McMurray
,
John R Teerlink
Added:
6 years ago
Summary
This Satellite Symposium - Experts on the Spot session titled ‘Optimising treatment of heart failure – where are we today?’ was moderated by Frank Ruschitzka. This session provided delegates the opportunity to ask questions to the expert faculty panelists; John McMurray and John Teerlink, following the two Novartis-sponsored Satellite Symposia on acute and chronic heart failure at ESC…
View more
Author(s):
Piotr Ponikowski
Added:
8 years ago
Author(s):
Giuseppe Rosano
,
Ilaria Spoletini
,
Cristiana Vitale
,
et al
Added:
3 years ago
Heart failure (HF) affects 1–2% of the population in developed countries and absorbs a significant amount of human and economic resources.1,2 HF is a complex syndrome characterised by a spectrum of symptoms and phenotypes: HF with preserved ejection fraction, HF with mid-range ejection fraction and HF with reduced ejection fraction (HFrEF).3 Differentiating patients according to left ventricular…
View more
Navin K Kapur
Job title: Associate Professor
Author
Author(s):
Martin R Cowie
,
Michel Komajda
Added:
3 years ago
Advances in diagnosis and treatment have improved the outlook for the estimated 26 million patients with heart failure (HF) worldwide,1 but there remains a continuing need for further reduction in mortality and hospitalisation and the associated social and financial consequences of the disease. In a European study of outcomes after HF hospitalisation, 17 % of patients died within 12 months and 44…
View more
Author(s):
Frank Ruschitzka
Start date:
May 27, 2018
Sunday 27 May: Satellite Symposium →
Sunday 27 May: Satellite Symposium – Experts on the Spot →
Please note this content is not intended for
healthcare professionals licensed in the USA. Please use Internet Explorer or
Firefox browser to view the Live Stream -->
Novartis sponsored Satellite Symposium at Heart Failure 2018 Congress
Resolving dilemmas in the treatment of heart failure
…
View more